The European biotechnology industry has called on EU politicians to increase support for R&D on genetically modified organisms and boost funding for small businesses.
EuropaBio, which represents bioscience companies, published a manifesto for the newly-appointed European Parliament and European Commission on 3 November. It sets out what the industry expects from European politicians for the 2014-2019 period.
The group says policymakers should develop an action plan to reduce the backlog of pending approvals for genetically modified organisms (GMOs), and deal with legal uncertainty in this area. The manifesto states that Europe has less science-based regulatory frameworks in this area, and lacks funding compared to other parts of the world. The GMO issue is still highly polarised in Europe, and biotech companies want less stringent regulations to be applied in their research development of products.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.